[  概要   |   プレカンファレンス   |   1日目   |   2日目   |   3日目   |   カタログ(PDF)  ]

Hear comprehensive coverage on:

• DEVELOPING microRNA TOOLS INTO TISSUE-SPECIFIC DIAGNOSTIC MARKERS

• microRNA DYSFUNCTION REGULATION

• PATHWAY ANALYSIS FEATURES TO MODEL ORGANISM DATABASES

• TOXICITY PATHWAYS

• REAL IMPACT OF PATHWAY TOOLS

• PATHWAY APPROACH TO UNDERSTANDING OFF-TARGET EFFECTS

HIGHLIGHTED PRESENTATIONS:

George A. Calin, M.D., Ph.D. Associate Professor, Department of Experimental Therapeutics University of Texas, MD Anderson Cancer Centre

Andrea Califano, Ph.D. Professor and Director, Genome Center Bioinformatics Columbia University

Pablo Landgraf, M.D., Ph.D. Group Leader, Department of Pediatric Oncology, Hematology and Clinical Immunology Children's Hospital of the Heinrich-Heine University D・seldorf

Isidore Rigoutsos, Ph.D. Manager, Bioinformatics & Pattern Discovery Group, Computational Biology Center IBM Thomas J. Watson Research Center

Peter Karp, Ph.D. Director, Bioinformatics Research Group, SRI International

Rex Chisholm, Ph.D. Director, Genetic Medicine, RH Lurie Cancer Center Northwestern University

Jeff Kiefer, Ph.D. Head of Knowledge Mining and Bioinformatics, Pharmaceutical Genomics Division
TGEN

Arthur L. Holden Chairman and CEO International SAE Consortium, Ltd.

Phil Hewitt, Ph.D. UK and Eurotox Registered Toxicologist, Head of Toxicogenomics, Non Clinical Development Toxicology Darmstadt Merck Serono Research

John K. Westwick, Ph.D. President and Chief Executive Officer Odyssey Thera, Inc.